View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
June 19, 2019
learn more
Newsletter Sponsor
   Cambrex Highly Potent API Development & Manufacturing Services

Cambrex offers clients a truly end-to-end partnership for the research, development and manufacture of small molecule highly potent APIs (HPAPIs) across its global manufacturing network, to support a drug at every stage of its lifecycle. With flexible assets in its facilities across the USA and Europe, Cambrex covers HPAPI containment occupational exposure limits (OEL) from 10 down to <0.1>3.

more info

» Industry News
 
more news
» Featured Articles
The Evolving Shape of the ADC Market
The scale of patient demand has fuelled an overarching healthcare market need to expand the drug development pipeline to generate more biologics to treat multiple diseases and innovative new ... read more »
Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials
One of the major challenges when undertaking a first-in-human (FIH) clinical trial is how to appropriately plan and analyze the pharmacokinetics (PK) of a new drug. Although PK assessment in the ... read more »
more articles
 
» Featured Video
learn more
  Watch Webinar: From DNA Sequence to GMP Manufacturing
From DNA Sequence to GMP Manufacturing read more »
learn more
  Watch Video: Mark Egerton, CEO of Quotient Sciences, Interview at AAPS 2017
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial... read more »

more videos
 
» Featured Whitepaper
Host Cell Protein Analysis in Biologic Drug Development
This whitepaper reviews fundamental aspects of HCPs that pertain to biologic drug development and presents current and emerging approaches to HCP ... read more »
Process Development for Lyophilized Products
Identifying the failure points for a product is a necessary part of product development, and enables the development scientist to design a ... read more »
more articles
 
| Events
EVENT
  Clinical Operations in Oncology Trials East Coast 2019
Cambridge, MA –  07/10/2019
The Clinical Operations in Oncology Trials (CTO) meeting returned to Boston for its 6th year with over 150 attendees from biopharmaceutical, medical ... event details »
EVENT
  Highly Potent Active Pharmaceuticals Ingredients
Boston, MA –  10/21/2019
The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a ... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA